American Heart Journal 2001: Vol 142 Index

31 Pages·2001·9 MB·English

Author index * nold M (see White et al). 2001;142:1056-64
onow HD, Peyser PA, Eagle KA, Bates ER, Werns SW, Russman
PI rum MA, Harris Kk, Moscucci M. Predictors of length of
Stay after coronary stenting. 2001;142:799-805
Asai M (see Yamada et al). 2001;142:286-93
A
Asano Y (see Yamada et al). 2001;142:286-93
Abdellaoui M (see Ben-Farhat et al). 2001;142:107 Atwood JE (see Prakash et al). 2001;142:127-35
Abdollah H (see Simpson et al). 2001;142:e3 Au DH (see Udris et al). 2001;142:1003-9
Acanfora D, Gheorghiade M, Trojano L, Furgi G, Pasini E, Picone Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B
C, Papa A, lannuzzi GL, Bonow RO, Rengo F, CHF Italian Subclinical hyperthyroidism as a risk factor for atrial fibrilla
Study Investigators. Relative lymphocyte count: a prognostic tion. 2001;142:838-42
indicator of mortality in elderly patients with congestive heart AVID Investigators (see Ehlert et al). 2001;142:816-22
failure. 2001;142:167-73 AVID Investigators (see Steinberg et al). 2001;142:520-9
Acusta AP (see Joglar et al). 2001;142:498-501 Awata N (see Izumi et al). 2001;142:782-9
Addad F (see Ben-Farhat et al). 2001;142:1072-9 Azzolini P (see Padeletti et al). 2001;142:1047-55
AhmedJM (see Castagna et al). 2001;142:970-4
Ajani U (see White et al). 2001;142:1056-64
Alaghband-Zadeh J (see Al-Obaidi et al). 2001;142:1002
Albert N (see Yamani et al). 2001;142:998-1002
Albertal M, Regar E, Piek JJ, Van Langenhove G, Carlier SG, Thury
A, Sianos G, Boersma E, de Bruyne B, di Mario C, Serruys PW Bader D (see Myers et al). 2001:142:1041-6
Doppler Endpoints Balloon Angioplasty Trial Europe Badry JT (see Graham et al). 2001;142:254-61
(DEBATE) Study Group. Value of coronary stenotic flow veloc Bagger JP (see Zachariae et al). 2001;142:63-71
ity acceleration on the prediction of long-term improvement in Bahit MC, Cabell CH, Dyke CK, Felker GM, Kaul P, McGuire DK,
functional status after angioplasty. 2001;142 81-6 O'Shea JC, Reddan D, East M. Highlights from the American
Alexander KP, Galanos AN, Jollis JG, Stafford JA, Peterson ED College of Cardiology 50th Annual Scientific Sessions: March
Post-myocardial infarction risk stratification in elderly patients 18 to 21, 2001. 2001;142:363-74. Correction 2001:142:678
2001;142:37-42 Baim DS (see Cohen et al). 2001;142:648-56
Alexander KP (see Pasquali et al). 2001;142:748-55 (Curriculum Balan KK, Critchley M. Is the dyspnea during adenosine cardiac
cardiol. ) stress test caused by bronchospasm? 2001;142:142-5
Altmann C (see Wieneke et al). 2001;142:691-7 BanasJS Jr (see Bisaccia et al). 2001;142:461-5
Altmann E (see Zahn et al). 2001;142:105-11 Banerjee A (see Salaymeh and Banerjee). 2001;142:549-55
Altunkeser BB (see Ozdemir et al). 2001;142:1065-71 Barbeau G (see Dzavik et al). 2001;142:301-8
Amersey RA (see Al-Obaidi et al). 2001;142:1002 Barber G (see Silber et al). 2001;142:577-85 (Trial design)
Anders RJ (see White et al). 2001;142:1010-5 Barbera SJ (see Joglar et al). 2001;142:498-501
Anderson DJ (see Cabell et al). 2001;142:75-80 Barlera S (see Volpi et al). 2001;142:87-92
Anderson DJ (see Meine et al). 2001;142:280-5 Barnard MR (see Furman et al). 2001;142:790-8
Anderson HV (see Peters et al). 2001;142:237-43 Jarnes J (see Al-Obaidi et al). 2001;142:1002
Anderson JL (see Ehlert et al). 2001;142:816-22 Barron HV (see Manhapra et al). 2001;142:604-10
Anderson TE (see Dzavik et al). 2001;142:301-8 3art BA (see Whellan et al). 2001;142:160-6
Andrén B (see Arnlév et al). 2001;142:720-4 Barvais L (see de Canniére et al). 2001;142:563-70 (Prog. cardiol.)
Angel C (see Losay et al). 2001;142:544-8 ,ashore TM (see Krucoff et al). 2001;142:760-7
Anker SD (see Cicoira et al). 2001;142:174-80 Bata IR (see Nassar et al). 2001;142:586-9
Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Laurenti A Bates ER (see Aronow et al). 2001;142:799-805
Fedele F, Santini M. Doppler myocardial imaging in patients Baumann FG (see Kort et al). 2001;142:476-81
with heart failure receiving biventricular pacing treatment Baumgart D (see Wieneke et al). 2001;142:691-7
2001:142:881-96 Bax JJ (see Sozzi et al). 2001;142:153-9
Anthony M (see Bleske et al). 2001;142:e2 Beck CA, Joseph L, Beélisle P, Pilote L, QOLAMI Investigators.
Antman EM, Braunwald E. A second look at bivalirudin Predictors of quality of life 6 months and 1 year after acute
2001;142:929-31 (Editorial) myocardial infarction. 2001;142:271-9
Antman EM (see Henry et al). 2001;142:590-3 Becker RC (see Li et al). 2001;142:204-10 (Prog. cardiol.)
Antman EM (see Srinivas et al). 2001;142:29-36 Bedi A (see Das et al). 2001;142:756-9 (Curriculum cardiol.)
Antonio C (see Kumar et al). 2001;142:512-15 Bélisle P (see Beck et al). 2001;142:271-9
Antoniucci D, Valenti R, Migliorini A, Moschi G, Bolognese | Ben-Farhat M, Betbout F, Gamra H, Maatouk F, Ben-Hamda K,
Cerisano G, Buonamici P, Santoro GM. Direct infarct artery Abdellaoui M, Hammami S, Jarrar M, Addad F, Dridi Z
stenting without predilation and no-reflow in patients with Predictors of long-term event-free survival and of freedom
acute myocardial infarction. 2001;142:684-90 from restenosis after percutaneous balloon mitral commissuro-
Antonucci LC (see Bisaccia et al). 2001;142:461-5 tomy. 2001;142:1072-9
Applebaum RM (see Kort et al). 2001;142:476-81 Ben-Hamda K (see Ben-Farhat et al). 2001;142:1072-9
APPROACH Investigators (see Dzavik et al). 2001;142:119-26 Benedetta M (see Gattone et al). 2001;142:633-40
APPROACH Investigators (see Graham et al). 2001;142:254-61 Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the
Armstrong PW (see O'Shea et al). 2001;142:14-20 (Meetings) coronary arteries. 2001;142:402-10 (Curriculum cardiol.)
Arnlév J, Lind L, Zethelius B, Andrén B, Hales CN, Vessby B, Lithell Berezin RH (see Cohen et al). 2001;142:648-56
H. Several factors associated with the insulin resistance syn Berger PB, Dzavik V, Penn IM, Catellier D, Buller CE, TOSCA
drome are predictors of left ventricular systolic dysfunction in a Investigators. Does ticlopidine reduce reocclusion and other
male population after 20 years of follow-up. 2001;142:720-4 adverse events after successful balloon angioplasty of occlud-
ed coronary arteries? Results from the Total Occlusion Study of
*July, pp. 1-196; August, pp. 197-374, $1-30; September, pp. 375-562; Canada (TOSCA). 2001;142:776-81
October, pp. 563-744; November, pp. 745-928; December, pp. 929 Berger PB (see Al Suwaidi et al). 2001;142:452-9
1146 Berger PB (see Dzavik et al). 2001;142:301-8
December 2001 American Heart Journal 1117
Berglind S$ (see Strandberg et al). 2001;142:952-9 (Trial design) Briggs AH (see Levy et al). 2001;142
Berkowitz SD. Antithrombotic therapy after prosthetic cardiac Broderick TM (see Furman et al). 2001;142:790-8
valve implantation: potential novel antithrombotic therapies Brodie BR. Reperfusion therapy for acute myocardial infarction in
2001;142:7-13 (Meetings) patients with prior bypass surgery. 2001;142:381-3 (Editorial)
Bertel O (see Schalcher et al). 2001;142:340-9 Brown DL (see Huynh et al). 2001;142:960-4
Berthaux X (see Losay et al). 2001;142:544-8 Brown DL (see Kovar et al). 2001:142:e9
Bertolo O (see Palatini et al). 2001;142:1016-23 Brown DW, Giles WH, Croft JB. Hematocrit and the risk of coro
Beshai J (see Passman et al). 2001;142:806-10 nary heart disease mortality. 2001;142:657-63
Betbout F (see Ben-Farhat et al). 2001;142:1072-9 Brown M (see Prasad et al). 2001;142:248-53
Bevin LD (see Nassar et al). 2001;142:586-9 Buller C (see Sadanandan et al). 2001;142:411-21 (Prog. cardiol.)
Bhakta D (see Xie et al). 2001;142:331-5 Buller CE (see Berger et al). 2001;142:776-81
Bhatt DL (see Mukherjee et al). 2001;142:72-4 BullerC E (see Dzavik et < 2001;142:301-8
Bierig M (see Dolan et al). 2001;142:908-15 Buonamici P (see Antonit t al). 2001;142:684-90
Bilheimer D (see Blazing et al). 2001;142:211-17 (Trial design)
Birgelen C von (see Wieneke et al). 2001;142:691-7
Bisaccia E, Klainer AS, Gonzalez J, Schwartz J, Randazzo D,
Antonucci LC, Shioleno CA, Eisen HJ, BanaJsS Jr. Feasibility of
photopheresis to reduce the occurrence of restenosis after per
cutaneous transluminal coronary angioplasty: a clinical pilot abell CH, Pond KK, Peterson GE, Durack DT, Corey GR,
study. 2001;142:461-5 Anderson DJ, Ryan T, Lukes AS, Sexton DJ. The risk of stroke
Bittl JA, Chaitman BR, Feit F, Kimball W, Topol EJ, Bivalirudin and death in patients with aortic and mitral valve endocarditis
Angioplasty Study Investigators. Bivalirudin versus heparin 2001:142:75-80
during coronary angioplasty for unstable or postinfarction abell CH (see Bahit et al). 2001;142:363-7 Correction
angina: final report reanalysis of the Bivalirudin Angioplasty 2001;142:678
Study. 2001;142:952-9 abell CH (see Meine et al). 2001;142:280-5
Bivalirudin Angioplasty Study Investigators (see Bittl et al) califf RM (see Blazing et al). 2001;142:211-17 (Trial design)
2001;142:952-9 aliff RM (see Donahue et al). 2001;142:1088-90 (Meetings)
Bjerring P (see Zachariae et al). 2001;142:63-71 aliff RM (see Kandzari et al). 2001;142:843-51
Bjornerheim R (see Qi et al). 2001;142:725-32 aliff RM (see Lundergan et al). 2001;142:43-50
Black HR (see White et al). 2001;142:1010-5 aliff RM (see Whellan et al). 2001;142:160-6
Blackburn GL (see Khaodhiar and Blackburn). 2001;142:1095-101 annom DS (see Ehlert et al). 2001;142:816-22
(Meetings) annon CP (see Srinivas et al). 2001;142:29-36
Blazing MA, de Lemos JA, Dyke CK, Califf RM, Bilheimer D, anto JG (see Manhapra et al). 2001;142:604-10
Braunwald E. The A-to-Z Trial: methods and rationale for a apucci A (see Padeletti et al). 2001;142:1047-55
single trial investigating combined use of low-molecular arere RG (see Dzavik et al). 2001;142:301-8
weight heparin with the glycoprotein [b/IIa_ inhibitor arlier SG (see Albertal et al). 2001;142:81-6
tirofiban and defining the efficacy of early aggressive simvas arlsson J (see Miketic et al). 2001;142:e8
tatin therapy. 2001;142:211-17 (Trial design) arney RM (see Sheps et al). 2001;142:864-71
Bleske BE, Willis RA, Anthony M, Casselberry N, Datwani M, arrozza JP (see Cohen et al). 2001;142:648-56
Uhley VE, Secontine SG, Shea MJ. The effect of pravastatin asselberry N (see Bleske et al). 2001;142:e2
and atorvastatin on coenzyme Q10. 2001;142:e2 astagna MT, Mintz GS, Leiboff BO, Ahmed JM, Mehran R, Satler
Bocchicchio M (see Kimura et al), 2001;142:324-30 LF, Kent KM, Pichard AD, Weissman NJ. The contribution of
Boersma E (see Albertal et al). 2001;142:81-6 mechanical” problems to in-stent restenosis: an intravascular
Boersma E (see $ozzi et al). 2001;142:153-9 ultrasonographic analysis of 1090 consecutive in-stent resteno
Bolognese L (see Antoniucci et al). 2001;142:684-90 sis lesions. 2001;142:970-4
Bolson E (see Wong et al). 2001;142:897-907 atellier D (see Berger et al). 2001;142:776-81
Bonanno C (see La Vecchia et al). 2001;142:181-9 atellier D (see Dzavik et al). 2001;142:301-8
Bondmass MD (see Strzelezyk et al). 2001;142:466-75 avalli A (see Volpi et al). 2001;142:87-92
Bonow RO (see Acanfora et al). 2001;142:167-73 eci V (see Ricci et al). 2001;142:e5
Bonow RO (see Henry et al). 2001;142:872-80 erisano G (see Antoniucci et al). 2001;142:684-90
Bonsall R (see Sheps et al). 2001;142:864-71 haitman BR (see Bittl et al). 2001;142:952-9
Borghetti A (see Sozzi et al). 2001;142:153-9 hang W-C (see O'Shea et al). 2001;142:14-20 (Meetings)
Boriani G (see Padeletti et al). 2001;142:1047-55 then J (see Ross et al). 2001;142:244-7
Borzak S (see Manhapra et al). 2001;142:604-10 hen J (see Wexler et al). 2001;142:350-7
Bottero G (see Ricci et al). 2001;142:e5 hen L (see Udris et al). 2001;142:1003-9
Botto GL (see Padeletti et al). 2001;142:1047-55 therian F (see McFarlane et al). 2001;142:617-23
Boyle D (see Lundergan et al). 2001;142:43-50 heriparambil K (see Das et al). 2001;142:756-9 (Curriculum cardi-
Bradford WD (see Wexler et al). 2001;142:350-7 ol )
Brandrup-Wognsen G (see Vargas et al). 2001;142:1080-7 hesebro JH (see Mathew et al). 2001;142:768-73
Braney M (see Simpson et al). 2001;142:294-300 HF Italian Study Investigators (see Acanfora et al). 2001;142:167-
Brasch AV, Mohsenifar Z, Jeon D-S, Luo H, Mirocha JM, Khan SS, 2
Siegel RJ. Aortic root dilatation in patients with emphysema hin AJ (see Silber et al). 2001;142:577-85 (Trial design)
2001;142:1024-7 hitwood WR Jr. Minimally invasive aortic valve surgery: what is
Braunwald E (see Antman and Braunwald). 2001;142:929-31 port access”? 2001;142:391-2 (Editorial)
(Editorial) thoi JW, Goodreau LM, Davidson CJ. Resource utilization and
Braunwald E (see Blazing et al). 2001;142:211-17 (Trial design) clinical outcomes of coronary stenting: a comparison of
Braunwald E (see Pfeffer et al). 2001;142:375-7 (Editorial) intravascular ultrasound and angiographical guided stent
Braunwald E (see Srinivas et al). 2001;142:29-36 implantation. 2vU1;142:112-18
Brenot P (see Losay et al). 2001;142:544-8 thoudhary G (see Kumar et al). 2001;142:512-15
Brieger D (see Huynh et al). 2001;142:960-4 ‘hun S$ (see Matsushita et al). 2001;142:664-8
yy inae| x
Ciapetti C (see Padeletti et al). 2001;142:1047-55 le Bruyne B (see Albertal et al). 2001;142:81-6
CIBIS-2 Investigators (see Funck-Brentano et al). 2001;142:989-97 le Canniere D, Jansens J-L, Goldschmidt-Clermont P, Barvais L,
Cicoira M, Davos CH, Florea V, Shamim W, Doehner W, Coats AJS Decroly P, Stoupel E. Combination of minimally invasive coro
Anker SD. Chronic heart failure in the very elderly: clinical sta nary bypass and percutaneous transluminal coronary angio
tus, survival, and prognostic factors in 188 patients more than plasty in the treatment of double-vessel coronary disease: two-
70 years old, 2001;142:174-80 follow-up of a new hybrid procedure compared with
lapp-Channing N (see Kandzari et al). 2001;142:843-51 double bypass grafting. 2001;142:563-70 (Prog
lark BJ (see Silber et al). 2001;142:577-85 (Trial design)
naan A (see Silber et al). 2001;142:577 85 (Trial design) rinMa (s ee Gianettie t al), 2001;142:7
oats AJS (see Cicoira et al), 2001;142:174-80 R (see Gianettie t al). 2001;142:7
ohen DJ, Ramee S, Baim DS, Sharma S, Carrozza JP, Cosgrove R l (see Gianettie t al). 2001:142
Jones N, Berezin RH, Cutlip DE, Ho KKL, Kuntz RE, Vein Graft mos JA (see Blazing et al). 2001;142:211-17 (Trial design)
Angiojet Study (VeGAS) 2 Investigators. Economic assessment de Lemos JA (see Srinivas et al). 2001:142:29-36
of rheolytic thrombectomy versus intracoronary urokinase for Decroly P (see de Canniéree t al), 2001;142:563-70 (Prog. cardiol.)
treatment of extensive intracoronary thrombus: results from a P (see Wedeetl a l). 2001;142:502-11
randomized clinical trial. 2001;142:648-56 -ouchi Y (see Tanabe et al). 2001:142:669-78
Cohen EA (see Dzavik et al). 2001;142:301-8 | GueRr (sece Giianeotti et al). 2001;142:733-9
Cohen JD (see Sheps et al). 2001;142:804-71 t C (see Silber et al). 2001;142:577-85 (Trial design)
Cohen MI (see Silber et al). 2001;142:577-85 (Trial design) nul U (see Huyneth al ). 2001;142:960-4
Cohen V (see Benzaquen et al). 2001;142:402-10 (Curriculum cat Dellborg M (see Johanson et al). 2001;142:58-62
diol.) DeMaria AN (see Kimura et al). 2001;142:324-30
Colan SD (see Kay et al). 2001;142:923-8 (Meetings) Demers C, McKelvie RS, Negassa A, Yusuf S$, RESOLVD Pilot Study
Colella A (see Padeletti et al). 2001;142:1047-55 Investigators. Reliability, validity, and responsiveness of the
Coletta C (see Ricci et al). 2001;142:e5 six-minute walk test in patients with heart failure. 2001;
Collins P (see Ong et al). 2001;142:e6 142:098-703
Colombo M (see Gattone et al). 2001;142:633 Demers C (see Levy et al). 2001;142:537-43
Colvin SB (see Kort et al). 2001;142:476-81 DeMets D (s Wedel et al). 2001;142:502-11
Comella K (see Mukherjee et al). 2001;142:72 i DeMets DL (see O'Shea and DeMets). 2001;142:21-8 (Meetings)
Connuck D (see Mehta et al). 2001;142:828-32 Devlin WH (see George et al). 2001:142:857-63
Coombes RC (see Ong et al) Di Castelnuovo A (see Gattone et al). 2001;142:633-40
Corey GR (see Cabell et al). 2001;142:75-80 di Mario C (see Albertal et al). 2001;142:81-6
Corey GR (see Meine et al). 2001; 142:280-5 Dib N (see Shubrooks et al). 2001;142:190-6
Corpus RA (see George et al), 2001;142:857-63 Dilaveris P, Pantazis A, Gialafos E, Triposkiadis F, Gialafos J. The
Correa SD (see Schaefer et al). 2001;142:e4 effects of cigarette smoking on the heterogeneity of ventricular
Cosgrove R (see Cohen et al). 2001;142:648-56 repe larization. 2001;142:833
Cotter G (see Schalcher et al). 2001;142:340-9 Dirsch O (see Wieneke et al). 2001;142:691-7
Coyne KS (see Lundergan et al). 2001;142 3-50 Do D (see Prakash et al). 2001;142:127-35
Coyne KS (see Ross et al). 2001;142 2A4- Doehner W (see Cicoira et al). 2001:142:174-80
Crater SW (see Krucoff et al). 2001;142:760-7 Dolan MS, Riad K, El-Shafei A, Puri S$, Tamirisa K, Bierig M, St
Critchley M (see Balan and Critchley). 2001;142:142-5 Vrain J, McKinney L, Havens E, Habermehl K, Pyatt L, Kern M,
Croft JB (see Brown et al). 2001;142:657-63 Labovitz AJ. Effect of intravenous contrast for left ventricular
Crowley |] (see Lederman et al). 2001;142:314-23 opacification and border definition on sensitivity and specifici-
Croxton M (see Miele et al). 2001;142:571-6 (Curriculum cardiol. ) ty of dobutamine stress echocardiography compared with
Crum MA (see Aronow et al). 2001:142:799-805 coronary angiography in technically difficult patients.
Csako G (see Prasad et al). 2001;142:248-53 2001;142:908-15
Cummings CC (see Serebruany et al). 2001;142:611-16 Doliszny K (see Vargas et al). 2001;142:1080
Curtis AB (see Hickey et al). 2001;142:99-104 Domanski M (see Pfeffer et al). 2001;142:375-7 (Editorial)
Curtis MJ (see Graham et al). 2001;142:254-61 Domanski M (see Steinberg et al). 2001;142:520-9
Cusick DA (see Strzelezyk et al). 2001;142:466-75 Donahue M, Fuster V, Califf RM. Obesity and cardiovascular dis-
Cutlip DE (see Cohen et al). 2001;142:648-56 ease—Introduction: cardiologists should target obesity.
2001;142:1088-90 (Meetings)
Donahue M (see Rao et al). 2001;142:1102-7 (Meetings)
Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE)
D Study Group (see Albertal et al). 2001;142:81-6
Downey M. Obesity as a disease entity. 2001;142:1091-4 (Meetings)
Da Col P (see Gelsomino et al). 2001;142:556-62 Drazner MH (see Rame et al). 2001;142:714-19
Dahdal M (see Al-Obaidi et al). 2001;142:1002 Dridi Z (see Ben-Farhat et al). 2001;142:1072-9
Dal Follo M (see Palatini et al). 2001;142:1016-23 Dries DL (see Rame et al). 2001;142:714-19
Daniele L (see Palatini et al). 2001;142:1016-23 Droszcz W (see Tendera et al). 2001;142:93-8
Daniels SR (see Kay et al). 2001;142:422-32 (Meetings) Dujovne CA, Zavoral JH, Rowe E, Mendel CM, Sibutramine Study
Darius H (see Kupferwasser et al). 2001;142:146-52 Group. Effects of sibutramine on body weight and serum
Das MK, Cheriparambil K, Bedi A, KassotisJ , Reddy CVR, Makan lipids: a double-blind, randomized, placebo-controlled study
M, Dunbar CC, Saul B. Prolonged QRS duration (QRS >170 in 322 overweight and obese patients with dyslipidemia.
ms) and left axis deviation in the presence of left bundle 2001;142:489-97
branch block: a marker of poor left ventricular systolic func- Dunbar CC (see Das et al). 2001:142:756-9 (Curriculum cardiol.)
tion? 2001;142:756-9 (Curriculum cardiol.) Dunlap M (see Pfeffer et al). 2001;142:375-7 (Editorial)
Datwani M (see Bleske et al). 2001;142:e2 Durack DT (see Cabell et al). 2001:142:75-80
Davidson C] (see Choi et al). 2001;142:112-18 Dvke CK (see Bahit et al). 2001;142:303-74. Correction 2001;142:
Davila-Roman VG (see Peterson et al). 2001;142:641-7 O/S
Davos CH (see Cicoira et al). 2001;142:174-80 Dyke CK (see Blazing et al). 2001;142:211-17 (Trial design)
Dzavik V, Carere RG, Mancini GB], Cohen EA, Catellier D, evidence-based approach. 2001;142:393-401 (Curriculum car
Anderson TE, Barbeau G, Lazzam C, Title LM, Berger PB diol.)
Labinaz M, Teo KK, Buller CE, Total Occlusion Study of Felker GM (see Bahit et al) 2001;142:363-7 Correction
Canada (TOSCA) Investigators. Predictors of improvement in 2001:142:678
left ventricular function after percutaneous revascularization of Fernandez-Avilés F (see San Roman et al). 2001;142:1037-40
occluded coronary arteries: a report from the Total Occlusion Fihn SD (see Udris et al). 2001;142:1003-9
Study of Canada (TOSCA). 2001;142:301-8 Fine JT (see Kandzari et al). 2001;142:843-51
Dzavik V, Ghali WA, Norris C, Mitchell LB, Koshal A, Saunders LD, Fink C (see Lundergan et al). 2001;142:43-50
Galbraith PD, Hui W, Faris P, Knudtson ML, APPROACH Fitzpatrick P (see Shubrooks et al). 2001;142:190-6
Investigators. Long-term survival in 11,661 patients with multi Fitzsimmons PJ], McWhirter PD, Peterson DW, Kruyer WB. The
vessel coronary artery disease in the era of stenting: a report natural history of Wolff-Parkinson-White syndrome in 228 mil
from the Alberta Provincial Project for Outcome Assessment in itary aviators: a long-term follow-upo f 22 years. 2001;142:530
Coronary Heart Disease (APPROACH) — Investigators 6
2001; 142:119-26 Flaker GC (see Pfeffer et al). 2001:142:375-7 (Editorial)
Dzavik V (see Berger et al). 2001;142:776-81 Fleischer TA (see Prasad et al). 2001;142:248-53
Dzavik V (see Sadanandan et al). 2001;142:411-21 (Prog. cardiol.) Florea V (see Cicoira et al). 2001;142:174-80
Fogel MA, Hubbard A, Weinberg PM. A simplified approach for
assessment of intracardiac baffles and extracardiac conduits in
congenital heart surgery with two-and three-Ccimensional mag
netic resonance imaging. 2001;142:1028-36
Fontanelli A (see La Vecchia et al). 2001;142:181-9
Eagle KA (see Aronow et al). 2001;142:799-805 Fournier C (see Nikpoor et al). 2001;142:336-9
East M (see Bahit et al). 2001;142:303-74. Correction 2001;142:678 Fox ML (see Furman et al). 2001;142:790-8
Eber B (see Auer et al). 2001;142:838-42 Fradley LG (see Mehta et al). 2001;142:828-32
Eber O (see Auer et al). 2001;142:838-42 Frassani R (see Gelsomino et al). 2001;14 2:556-62
Ehlert FA, Cannom DS, Renfroe EG, Greene HL, Ledingham R, Freedland KE (see Sheps et al). 2001;142:864-71
Mitchell LB, Anderson JL, Halperin BD, Herre JM, Luceri RM Frelinger AL II] (see Furman et al). 2001;142:790-8
Marinchak RA, Steinberg JS, AVID Investigators. Comparison French R (see Wong et al). 2001;142:897 907
of dilated cardiomyopathy and coronary artery disease in FrigoG (see Palatini et al). 2001;142:1016-23
patients with life-threatening ventricular arrhythmias: differ Frobert O (see Zachariae et al). 2001;142:63-71
ences in presentation and outcome in the AVID registry Froelicher V (see Myers et al). 2001;142:1041-6
2001;142:816-22 Froelicher VF (see Gauri et al). 2001;142:136-41
Eisen HJ (see Bisaccia et al). 2001;142:461-5 Froelicher VF (see Prakash et al). 2001;142:127-35
Eisenberg MJ (see Benzaquen et al). 2001;142:402-10 (Curriculum Froning J (see Prakash et al). 2001;142:127-35
cardiol.) Fu Y (see O'Shea et al). 2001;142:14-20 (Meetings)
Eisenberg MJ (see Huynh et al). 2001;142:960-4 Fukuda T (see Inoue et al). 2001;142:740-4
Eisenstein EL (see Kandzari et al). 2001;142:843-51 Fukunami M (see Yamada et al). 2001;142:286-93
Elhendy A (see Sozzi et al). 2001;142:153-9 Fukushi H (see Tanabe et al). 2001;142:669-78
Elliott WJ (see White et al). 2001;142:1010-5 Funamoto M (see Izumi et al). 2001;142:782-9
Ellis S (see Zhang et al). 2001;142:982-8 Funck-Brentano C, Lancar R, Hansen S$, Hohnloser SH, Vanoli E,
Ellis SG (see Mukherjee et al). 2001;142:72-4 CIBIS-2 Investigators. Predictors of medical events and of their
Endo M (see Yoshitomi et al). 2001;142:445-51 competitive interactions in the Cardiac Insufficiency Bisoprolol
Endo T (see Kosuge et al). 2001;142:51-7 Study 2 (CIBIS-2). 2001;142:989-97
Endresen K (see Qi et al). 2001;142:725-32 Furgi G (see Acanfora et al). 2001;142:167-73
Eppler SM (see Henry et al). 2001;142:872-80 Furman MI, Kereiakes DJ, Krueger LA, Mueller MN, Pieper K,
Erbel R (see Kupferwasser et al). 2001;142:146-52 Broderick TM, Schneider JF, Howard WL, Fox ML, Barnard
Erbel R (see Wieneke et al). 2001;142:691-7 MR, Frelinger AL II, Michelson AD. Leukocyte-platelet aggre
Esna G (see Losay et al). 2001;142:544-8 gation, platelet surface P-selectin, and platelet surface glyco
Every NR (see Manhapra et al). 2001;142:604-10 protein Ila after percutaneous coronary intervention: effects
Every NR (see Maynard et al). 2001;142:309-13 of dalteparin or unfractionated heparin in combination with
Eyster D (see Peterson et al). 2001;142:641-7 abciximab. 2001;142:790-8
Fuster V (see Donahue et al). 2001;142:1088-90 (Meetings)
Fuster V (see Rao et al). 2001;142:1102-7 (Meetings)
F
Fagerberg B (see Wedel et al). 2001;142:502-11 G
Fallen EL (see McFarlane et al). 2001;142:617-23
Faris P (see Dzavik et al). 2001;142:119-26 Galanos AN (see Alexander et al). 2001;142:47-42
Faris PD (see Graham et al). 2001;142:254-61 Galbraith PD (see Dzavik et al). 2001;142:119-26
Farkouh ME (see Mathew et al). 2001;142:768-73 Galbraith PD (see Graham et al). 2001;142:254-61
Fatema K (see Hirono et al). 2001;142:1023 Galloway AC (see Kort et al). 2001;142:476-81
Fearon WF (see Gauri et al). 2001;142:136-41 Gamra H (see Ben-Farhat et al). 2001;142:1072-9
Fedele F (see Ansalone et al). 2001;142:881-96 Gao R (see Ross et al), 2001;142:244-7
Feit F (see Bittl et al). 2001;142:952-9 Garcimartin I (see San Roman et al). 2001;142:1037-40
Feldman T (see Zhang et al). 2001;142:982-8 Gardner EB (see Rame et al). 2001;142:714-19
Felker GM, O'Connor CM. Between Scylla and Charybdis: the Garratt KN (see Al Suwaidi et al). 2001;142:452-9
choice of inotropic agent for decompensated heart failure Gattone M, lacoviello L, Colombo M, Di Castelnuovo A,
2001;142:932-3 (Editorial) Soffiantino F, Gramoni A, Picco D, Benedetta M, Giannuzzi P.
Felker GM, O'Connor CM. Inotropic therapy for heart failure: an Chlamydia pneumoniae and cytomegalovirus seropositivity,
Author index 1121
inflammatory markers, and the risk of myocardial infarction at Griffiths J (see Senaratne et al). 2001;142:975-81
a young age. 2001;142:633-40 Grill DE (see Al Suwaidi et al). 2001;142:452-9
Gauri AJ, Raxwal VK, Roux L, Fearon WF, Froelicher VF. Effects of Grill DE (see Mathew et al). 2001;142:768-73
chronotropic incompetence and B-blocker use on the exercise Gropler RJ (see Peterson et al). 2001;142:641-7
treadmill test in men. 2001;142:136-41 Grossi EA (see Kort et al). 2001;142:476-81
Gavora P (see Mazic et al). 2001;142:482-8 Gurbel PA (see Serebruany et al). 2001;142:611-16
Ge J (see Wieneke et al). 2001;142:691-7 GUSTO-I Angiographic Investigators (see Lundergan et al).
Gelsomino S, Frassani R, Morocutti G, Nucifora R, Da Col P, Minen 2001;1l4 2:43-50
G, Morelli A, Livi U. Time course of left ventricular remodeling Guyene T-T (see Schalcher et al). 2001;142:340-9
after stentless aortic valve replacement. 2001;142:556-62
George PB, Tobin KJ, Corpus RA, Devlin WH, O'Neill WW
freatment of cardiac risk factors in diabetic patients: how well
do we follow the guidelines. 2001;142:857-63 H
Gersh B (see Pfeffer et al). 2001;142:375-7 (Editorial)
Gersh BJ (see Mathew et al). 2001;142:768-73 Habermehl K (see Dolan et al). 2001;142:908-15
Gersh BJ (see Rathore et al). 2001;142:516-19 Haji SA (see Yamani et al). 2001;142:998-1002
Gershony G (see Zhang et al). 2001;142:982-8 Hales CN (see Arnlév et al). 2001;142:720-4
Ghali WA (see Dzavik et al). 2001;142:119-26 Hall C (see Qi et al). 2001;142:725-32
Ghali WA (see Graham et al). 2001;142:254-61 Hall C (see White et al). 2001;142:1056-64
Ghali WA (see Simpson et al). 2001;142:e3 Hallstrom A (see Steinberg et al). 2001;142:520-9
Gheorghiade M (see Acanfora et al). 2001;142:167-73 Halperin BD (see Ehlert et al). 2001;142:816-22
Gialafos E (see Dilaveris et al). 2001;142:833-7 Hamdan MH (see Joglar et al). 2001;142:498-501
Gialafos J (see Dilaveris et al). 2001;142:833-7 Hammami S$ (see Ben-Farhat et al). 2001;142:1072-9
Gianetti J, De Caterina M, de Cristofaro T, Ungaro B, Del Guercio Handa S (see Tanabe et al). 2001;142:669-78
R, De Caterina R. Intravenous prostaglandin E, reduces solu Hansen S (see Funck-Brentano et al). 2001;142:989-97
ble vascular cell adhesion molecule-1 in peripheral arterial Harcar-Sevcik RA (see Mehta et al). 2001;142:828-32
obstructive disease. 2001;142:733-9 Hare S (see Senaratne et al). 2001;142:975-81
Giannantoni P (see Ansalone et al). 2001;142:881-96 Harel F (see White et al). 2001;142:1056-64
Giannuzzi P (see Gattone et al). 2001;142:633-40 Harris K (see Aronow et al). 2001;142:799-805
Gibson CM (see Srinivas et al). 2001;142:29-36 HARVEST Study Group (see Palatini et al). 2001;142:1016-23
Gibson M (see Peters et al). 2001;142:237-43 Haude M (see Wieneke et al). 2001;142:691-7
Gieseler U (see Zahn et al). 2001;142:105-11 Havens E (see Dolan et al). 2001;142:908-15
Giles WH (see Brown et al). 2001;142:657-63 Hayashi K (see Shimizu et al). 2001;142:358-62
Gill VJ (see Miele et al). 2001;142:571-6 (Curriculum cardiol.) Hayward CS (see Ong et al). 2001;142:e6
Giordano F] (see Henry et al). 2001;142:872-80 Heagerty P (see Kim et al). 2001;142:934-44 (Curriculum cardiol.)
GISSI-3 Investigators (see Volpi et al). 2001;142:87-92 Heaney L (see Kumar et al). 2001;142:512-15
Gitt AK (see Zahn et al). 2001;142:105-11 Hendel RC (see Henry et al). 2001;142:872-80
Glynn R (see White et al). 2001;142:1056-64 Hennekens C (see White et al). 2001;142:1056-64
G6k H (see Ozdemir et al). 2001;142:1065-71 Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ,
Goldberg AD (see Pfeffer et al). 2001;142:375-7 (Editorial) Simons M, Losordo DW, Hendel RC, Bonow RO, Eppler SM,
Goldberg AD (see Sheps et al). 2001;142:864-71 Zioncheck TF, Holmgren EB, McCluskey ER. Intracoronary
Goldberg RJ (see Spencer et al). 2001;142:594-603 administration of recombinant human vascular endothelial
Goldner B (see Steinberg et al). 2001;142:520-9 growth factor to patients with coronary artery disease.
Goldschmidt-Clermont P (see de Canniére et al). 2001;142:563-70 2001:142:872-80
(Prog. cardiol.) Henry TD, Satran D, Knox LL, Iacarella CL, Laxson DD, Antman
Goldstein S (see Miele et al). 2001;142:571-6 (Curriculum cardiol.) EM. Are activated clotting tinies helpful in the management of
Goldstein S (see Wedel et al). 2001;142:502-11 anticoagulation with subcutaneous low-molecular-weight
Gomez CR (see Voros et al). 2001;142:916-22 heparin? 2001;142:590-3
Gonzalez J (see Bisaccia et al). 2001;142:461-5 Herlitz J, Karlson BW, Lindqvist J, Sjélin M. Important factors for
Goodreau LM (see Choi et al). 2001;142:112-18 the 10-year mortality rate in patients with acute chest pain or
Gore JM (see Spencer et al). 2001;142:594-603 other symptoms consistent with acute myocardial infarction
Gotsis W (see Kovar et al). 2001;142:e9 with particular emphasis on the influence of age. 2001;142:
Gottlieb S (see Wedel et al). 2001;142:502-11 624-32
Gottwik M (see Zahn et al). 2001;142:105-11 Herlitz J (see Vargas et al). 2001;142:1080-7
Goyal SB, Spodick DH. Electromechanical dysfunction of the left Herre JM (see Ehlert et al). 2001;142:816-22
atrium associated with interatrial block. 2001;142:823-7 Herrero P (see Peterson et al). 2001;142:641-7
Graff O (see Tendera et al). 2001;142:93-8 Hickey K, Curtis AB, Lancaster S, Larsen G, Warwick D, McAnulty
Graham HA (see Ong et al). 2001;142:e6 J, Mitchell LB. Baseline factors predicting early resumption of
Graham MM, Faris PD, Ghali WA, Galbraith PD, Norris CM, Badry driving after life-threatening arrhythmias in the Antiarrhyth-
JT, Mitchell LB, Curtis MJ, Knudtson ML, APPROACH mics Versus Implantable Defibrillators (AVID) Trial. 2001;142:
Investigators. Validation of three myocardial jeopardy scores in 99-104
a population-based cardiac catheterization cohort. 2001;142 Hirata A (see Yamada et al). 2001;142:286-93
254-61 Hirono O, Kubota I, Minamihaba O, Fatema K, Kato $, Nakamura
Graham TP Jr (see Kay et al). 2001;142:923-8 (Meetings) H, Tomoike H. Left ventricular diastolic dysfunction in patients
Gramoni A (see Gattone et al). 2001;142:633-40 with bronchial asthma with long-term oral B,-adrenoceptor
Greaves S (see White et al). 2001;142:1056-64 agonists. 2001;142:1023 -
Green CL (see Krucoff et al). 2001;142:760-7 Hirsh J. Modulating the coagulation cascade: new targets for
Greenberg MA (see Srinivas et al). 2001;142:29-36 antithrombotics and anticoagulants. 2001;142:S1-2 (Introduc-
Greenberg MD (see Solomon et al). 2001;142:811-15 tion), $30 (Conclusion)
Greene HL (see Ehlert et al). 2001;142:816-22 Hirsh J. New anticoagulants. 2001;142:S3-8
Hirsh J (see Peters et al). 2001;142:237-43 Joseph L (see Beck et al). 2001
Hjalmarson A (see Wedel et al). 2001;142:502-11 Just V (see Kumar et al). 2001
Ho KKL (see Cohen et al). 2001;142:648-56
HochmanJ S (see Sadanandan et al). 2001;142:411-21 (Prog. cardi
ol.)
Hogarty AN (see Silber et al). 2001;142:577-85 (Trial design)
Hohnloser SH (see Funck-Brentano et al). 2001;142:989-97
Hoki N (see Yamada et al). 2001;142:286-93 Kalisetti D (see Prakash et al). 2001;1 127-35
Holmes DRJ r (see Al Suwaidi et al). 2001;142:452-9 Kamath MV (see McFarlane et al). 2001;142:617-23
Holmes DR Jr (see Mathew et al). 2001;142:768-73 Kandzari DE, Lam LC, Eisenstein EL, Clapp-Channing N, Fine J1
Holmgren EB (see Henry et al). 2001;142:872-80 Califf RM, Mark DB, Jollis JG. Advanced coronary artery dis
Hon JKF (see Al-Obaidi et al). 2001;142:1002 ease: appropriate end points for trials of novel therapies
Hongo Y (see Kosuge et al). 2001;142:51-7 2001:142:843-51
Hori M (see Yamada et al). 2001;142:286-93 Kannam JP (see Mukamal et al). 2001;142:852-6
Howard WL (see Furman et al). 2001;142:790-8 Karlson BW (see Herlitz et al)
Hsia J (see Pfeffer et al). 2001;142:375-7 (Editorial) Karlsson T (see Vargas et al). 2001;142:1080-7
Hubbard A (see Fogel et al). 2001;142:1028-36 Kasagi F (see Tsuchihashi et al). 2001;142:e7
Hui W (see Dzavik et al). 2001;142:119-26 Kassotis ] (see Das et al). 2001;142:756-9 (Curriculum cardiol.)
Huynh T, Eisenberg MJ, Deligonul U, Tsang J, Okrainec K Kasza L (see Senaratne et al). 2001;142:975-81
Schechter D, Lefkovits J, Mak K-H, Brown DL, Brieger D, Kato S (see Hirono et al). 2001;142:1023
ROSETTA Investigators. Coronary stenting in diabetic patients Katz NM (see Solomon et al). 2001;142:811-15
results from the ROSETTA registry. 2001;142:900-4 Kaufman ES (see Mehta et al). 2001;142:828-32
Kaufmann PG (see Sheps et al). 2001;142:864-71
Kaul P (see Bahit et al). 2001;142:363-74. Correction 2001;142:678
Kawecka-Jaszcz K (see Tendera et al). 2001;142:93-8
Kay JD, Colan SD, Graham TP Jr. Congestive heart failure in pedi
atric patients. 2001;142:923-8 (Meetings)
lacarella CL (see Henry et al). 2001;142:590-3 Kay JD, Sinaiko AR, Daniels SR. Pediatric hypertension. 2001;142
lacoviello L (see Gattone et al). 2001;142:633-40 122-32 (Meetings)
lannuzzi GL (see Acanfora et al). 2001;142:167-74 Kelly L (see Yamani et al) 2:998-1002
Ikeda Y (see Kitai et al). 2001;142:e1 Kent KM (see Castagna et al) 1;142:970-4
Ino H (see Shimizu et al). 2001;142:358-62 Kereiakes D] (see Furman et al 142:790-8
Inoue T, Otaki M, Oku H, Fukuda T, Shinohara T. Follow-up study Kereiakes DJ] (see Henry et al). 2001;142:872-80
of coronary artery bypass grafting in patients with Kawasaki Kern M (see Dolan et al). 2001;142:908-15
disease. 2001;142:740-4 Ketterer MW (see Sheps et al). 2001;142:864-7
Isaka N (see Kitai et al). 2001;142:e1 Khan SS (see Brasch et al). 2001;142:1024-7
Ishikawa T (see Kosuge et al). 2001;142:51-7 Khaodhiar L, Blackburn GL. Obesity assessment. 2001;142:1095
Isner JM (see Henry et al). 2001;142:872-80 101 (Meetings)
Ito M (see Kitai et al). 2001;142:e1 Khattar RS, Senior R, Soman P, van der Does R, Lahiri A
Itoh H (see Shimizu et al). 2001;142:358-62 Regression of left ventricular remodeling in chronic heart fail
Iwaki T (see Shimizu et al). 2001;142:358-62 ure: comparative and combined effects of captopril and
Iwasawa Y (see Kosuge et al). 2001;142:51-7 carvedilol. 2001;142:704-13
Izumi M, Tsuchikane E, Funamoto M, Kobayashi T, Sumitsuji S Kilborn MJ (see Solomon et al). 2001;142:811-15
Otsuji S, Sakurai M, Kobayashi T, Awata N. Final results of the Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress
CAPAS trial. 2001;142:782-9 testing for coronary disease diagnosis: a meta-analysis
2001;142:934-44 (Curriculum cardiol.)
Kimball TR (see Silber et al). 2001;142:577-85 (Trial design)
Kimball W (see Bittl et al). 2001;142:952-9
J Kimmel S (see Passman et al). 2001;142:806-10
Kimura BJ, Bocchicchio M, Willis CL, DeMaria AN. Screening car
Jain A (see Kumar et al). 2001;142:512-15 diac ultrasonographic examination in patients with suspected
Jansens J-L (see de Canniére et al). 2001;142:5063-70 (Prog. cardi cardiac disease in the emergency department. 2001;142:324-30
ol ) Kimura K (see Kosuge et al). 2001;142:51-7
Jarrar M (see Ben-Farhat et al). 2001;142:1072-9 Kini A, Reich D, Marmur JD, Mitre CA, Sharma SK. Reduction in
Jeon D-S (see Brasch et al). 2001;142:1024-7 periprocedural enzyme elevation by abciximab after rotational
Jindal A (see Voros et al). 2001;142:916-22 atherectomy of type B, lesions: results of the Rota ReoPro ran-
Joglar JA, Acusta AP, Shusterman NH, Ramaswamy K, Kowal RC, domized trial. 2001;142:965-9
Barbera SJ, Hamdan MH, Page RL. Effect of carvedilol on sur Kiowski W (see Schalcher et al). 2001;142:340-9
vival and hemodynamics in patients with atrial fibrillation and Kirkland SA (see Nassar et al). 2001;142:586-9
left ventricular dysfunction: retrospective analysis of the US Kitai T, Nishikawa M, Tanigawa T, Okinaka T, Wada H, Shiku H,
Carvedilol Heart Failure Trials Program. 2001;142:498-501 Ikeda Y, Ito M, Isaka N, Nakano T. Inhibition by combined
Johanson P, ROssbergJ , Dellborg M. Continuous ST monitoring: a therapy with ticlopidine and aspirin of enhanced platelet
bedside instrument? A report from the Assessment of the aggregation during physical exercise in patients with coronary
Safety of a New Thrombolytic (ASSENT 2) ST Monitoring artery disease. 2001;142:e1
Substudy. 2001;142:58-62 Kjekshus J (see Qi et al). 2001;142:725-32
Johnson MF (see White et al). 2001;142:1010-5 Kjekshus J (see Wedel et al). 2001;142:502-11
Johnstone DE (see Nassar et al). 2001;142:586-9 Klainer AS (see Bisaccia et al). 2001;142:461-5
JollisJ G (see Alexander et al). 2001;142:37-42 Klein GJ] (see Simpson et al). 2001;142:294-300
JollisJ G (see Kandzari et al). 2001;142:843-51 Knack DL (see Yamani et al). 2001;142:998-1002
Jones N (see Cohen et al). 2001;142:648-56 Knox LL (see Henry et al). 2001;142:590-3
Author index 1123
Knudtson ML (see Dzavik et al). 2001;142:119-26 ahiri A (see Khattar et al). 2001;142:704-13
Knudtson ML (see Graham et al). 2001;142:254-61 Lam LC (see Kandzari et al). 2001;142:843-51
Kobayashi T (see Izumi et al). 2001;142:782-9 amas G (see Sadanandan et al). 2001;142:411-21 (Prog. cardiol.)
Kobayashi T (see Izumi et al). 2001;142:782-9 ambert V (see Losay et al). 2001;142:544-8
Kobrin I (see Schalcher et al). 2001;142:340-9 ancar R (see Funck-Brentano et al). 2001;142:989-97
Kodama K (see Tsuchihashi et al). 2001;142:e7 ancaster S (see Hickey et al). 2001;142:99-104
Koenig HG (see Krucoff et al). 2001;142:760-7 ane JD (see Krucoff et al). 2001:142:760-7
Kogulan PK (see Miele et al). 2001;142:571-6 (Curriculum cardiol.) angsteger W (see Auer et al). 2001;142:838-42
Koh KK (see Prasad et al). 2001;142:248-53 arsen G (see Hickey et al). 2001;142:99-104
Kojima S (see Yoshitomi et al). 2001;142:445-51 aslett LJ (see Schaefer et al). 2001;142:e4
Konno T (see Shimizu et al). 2001;142:358-62 auer RM, Sanders SP. Pediatric issues and diseases. 2001;142:224-
Kopecky SL (see Mathew et al). 2001;142:768-73 8 (Meetings)
Kort $, Applebaum RM, Grossi EA, Baumann FG, Colvin SB auer RM (see Sinaiko et al). 2001;142:229-32 (Meetings)
Galloway AC, Ribakove GH, Steinberg BM, Piedad B, Tunick auer RM (see Valente et al). 2001;142:433-9 (Meetings)
PA, Kronzon I. Minimally invasive aortic valve replacement aurenti A (see Ansalone et al). 2001;142:881-96
echocardiographic and clinical results. 2001;142:476-81 axson DD (see Henry et al). 2001;142:590-3
Koshal A (see Dzavik et al). 2001;142:119-26 aycock JF (see Al-Obaidi et al). 2001;142:1002
Kosinski E (see Stone et al). 2001;142:679-83 azzam C (see Dzavik et al). 2001;142:301-8
Kosuge M, Kimura K, Ishikawa T, Endo T, Hongo Y, Shigemasa 1 ederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS,
Iwasawa Y, Tochikubo O, Umemura S. ST-segment depression Crowley JJ. Primary renal artery stenting: characteristics and
in lead aVR predicts predischarge left ventricular dysfunction outcomes after 363 procedures. 2001;142:314-23
in patients with reperfused anterior acute myocardial infarc- Ledingham R (see Ehlert et al). 2001;142:816-22
tion with anterolateral ST-segment elevation. 2001;142:51-7 Lee JK (see Simpson et al). 2001;142:294-300
Kovar LI, Monrad ES, Sherman W, Kunchithapatham S, Ravi KL, Leeman D (see Shubrooks et al). 2001;142:190-6
Gotsis W, Silverman G, Brown DL. A randomized trial of stent- Lefkovits J (see Huynh et al). 2001;142:960-4
ing with or without balloon predilation for the treatment of Legget M (see Wong et al). 2001;142:897-907
coronary artery disease. 2001;142:e9 Leiboff BO (see Castagna et al). 2001;142:970-4
Kowal RC (see Joglar et al). 2001;142:498-501 Lessard D (see Spencer et al). 2001;142:594-603
Kozlowski JW (see Tendera et al). 2001;142:93-8 Levy AR, Briggs AH, Demers C, O’Brien BJ. Cost-effectiveness of
Krahn AD (see Simpson et al). 2001;142:294-300 B-blocker therapy with metoprolol or with carvedilol for treat-
Kraus WE (see Whellan et al). 2001;142:160-6 ment of heart failure in Canada. 2001;142:537-43
Kronzon I (see Kort et al). 2001;142:476-81 Levy CS (see Miele et al). 2001;142:571-6 (Curriculum cardiol.)
Krucoff MW, Crater SW, Green CL, Maas AC, Seskevich JE, Lane Lewis JM (see Shahi et al). 2001;142:263-70
JD, Loeffler KA, Morris K, Bashore TM, Koenig HG. Integrative Lewis SM (see Shubrooks et al). 2001;142:190-6
noetic therapies as adjuncts to percutaneous intervention dur- Li YF, Spencer FA, Becker RC. Comparative efficacy of fibrinogen
ing unstable coronary syndromes: Monitoring and and platelet supplementation on the in vitro reversibility of
Actualization of Noetic Training (MANTRA) feasibility pilot competitive glycoprotein IIb/IIIa (ollb/B,) receptor-directed
2001;142:760-7 platelet inhibition. 2001;142:204-10 (Prog. cardiol.)
Krueger LA (see Furman et al). 2001;142:790-8 Light KC (see Sheps et al). 2001;142:864-71
Krumholz HM (see Shahi et al). 2001;142:263-7( Limacher MC (see Pfeffer et al). 2001;142:375-7 (Editorial)
Krumholz HM (see Wexler et al). 2001;142:350-7 Linardou H (see Ong et al). 2001;142:e6
Kruyer WB (see Fitzsimmens et al). 2001;142:530-6 Lind L (see Arnlév et al). 2001;142:720-4
Krzeminska-Pakula M (see Tendera et al). 2001;142:93-8 Lindqvist J (see Herlitz et al). 2001;142:624-32
Kubota I (see Hirono et al). 2001;142:1023 Lithell H (see Arnlév et al). 2001;142:720-4
Kubota T (see Tsuchihashi et al). 2001;142:e7 Liu MW (see Voros et al). 2001;142:916-22
Kulakowski P (see Tendera et al). 2001;142:93-8 Livi U (see Gelsomino et al). 2001;142:556-62
Kumagai K (see Yamada et al). 2001;142:286-93 Loeffler KA (see Krucoff et al). 2001;142:760-7
Kumar A, Choudhary G, Antonio C, Just V, Jain A, Heaney L, Papp Losay J, Petit J, Lambert V, Esna G, Berthaux X, Brenot P, Angel C.
MA. Carvedilol titration in patients with congestive heart fail Percutaneous closure with Amplatzer device is a safe and effi-
ure receiving inotropic therapy. 2001;142:512-15 cient alternative to surgery in adults with large atrial septal
Kunchithapatham S (see Kovar et al). 2001;142:e9 defects. 2001;142:544-8
Kuntz RE (see Cohen et al). 2001;142:648-56 Losordo DW (see Henry et al). 2001;142:872-80
Kupferwasser LI, Darius H, Miller AM, Martin C, Mohr-Kahaly S, Luceri RM (see Ehlert et al). 2001;142:816-22
Erbel R, Meyer J. Diagnosis of culture-negative endocarditis Lucey DR (see Miele et al). 2001;142:571-6 (Curriculum cardiol.)
the role of the Duke criteria and the impact of transesophageal Luepker RV (see Vargas et al). 2001;142:1080-7
echocardiography. 2001;142:146-52 Lukes AS (see Cabell et al). 2001;142:75-80
Kuramochi M (see Yoshitomi et al). 2001;142:445-51 Lundergan CF, Ross AM, McCarthy WF, Reiner JS, Boyle D, Fink C,
Kwok YS (see Kim et al). 2001;142:934-44 (Curriculum cardiol.) Califf RM, Topol EJ, Simoons ML, Van Den Brand M, Van de
Werf F, Coyne KS, GUSTO-I Angiographic Investigators.
Predictors of left ventricular function after acute myocardial
infarction: effects of time to treatment, patency, and body
L mass index. 2001;142:43-50
Luo H (see Brasch et al). 2001;142:1024-7
La Vecchia L, Zanolla L, Varotto L, Bonanno C, Spadaro GL,
Ometto R, Fontanelli A. Reduced right ventricular ejection
fraction as a marker for idiopathic dilated cardiomyopathy
M
compared with ischemic left ventricular dysfunction
2001;142:181-9
Labinaz M (see Dzavik et al). 2001;142:301-8 Maas AC (see Krucoff et al). 2001;142:760-7
Labovitz AJ (see Dolan et al). 2001;142:908-15 Maatouk F (see Ben-Farhat et al). 2001;142:1072-9
1124 Author index
Mabuchi H (see Shimizu et al). 2001;142:358-62 LG, Harcar-Sevcik RA, Kaufman ES. Heart rate variability in
MacDonald K (see Senaratne et al). 2001;142:975-81 cocaine-exposed newborn infants. 2001;142:828-32
Maclure M (see Mukamal et al). 2001;142:852-6 Meine TJ, Nettles RE, Anderson DJ, Cabell CH, Corey GR, Sexton
Madhavan R (see Myers et al). 2001;142:1041-6 DJ, Wang A. Cardiac conduction abnormalities in endocarditis
Maggioni AP (see Pfeffer et al). 2001;142:375-7 (Editorial) defined by the Duke criteria. 2001;142:280-5
Mahoney EM (see Zhang et al). 2001;142:982-8 Melchiorsen H (see Zachariae et al). 2001;142:63-71
Maixner W (see Sheps et al). 2001;142:864-71 Menchavez E (see Steinberg et al). 2001;142:520-9
Mak K-H (see Huynh et al). 2001;142:960-4 Mendel CM (see Dujovne et al). 2001;142:489-97
Makan M (see Das et al). 2001;142:756-9 (Curriculum cardiol.) Mendelsohn FO (see Lederman et al). 2001;142:314-23
Malcolm V (see McFarlane et al). 2001;142:617-23 Menon V (see Sadanandan et al). 2001;142:411-21 (Prog. cardiol.)
Malinin AI (see Serebruany et al). 2001;142:611-16 MERIT-HF Study Group (see Wedel et al). 2001;142:502-11
Malmgren JA (see Manhapra et al). 2001;142:604-10 Messerli FH (see Ventura et al). 2001;142:197-203 (Curriculum cat
Malolepszy J (see Tendera et al). 2001;142:93-8 diol.)
Mancini GBJ (see Dzavik et al). 2001;142:301-8 Meyer J (see Kupferwasser et al). 2001;142:146-52
Manhapra A, Canto JG, Barron HV, MalmgreJnA , Taylor H, Rogers Michelson AD (see Furman et al). 2001;142:790-8
WJ, Weaver WD, Every NR, Borzak S. Underutilization of Miele PS, Kogulan PK, Levy CS, Goldstein $, Marcus KA, Smith
reperfusion therapy in eligible African Americans with acute MA, Rosenthal J, Croxton M, Gill VJ, Lucey DR. Seven cases of
myocardial infarction: role of presentation and evaluation surgical native valve endocarditis caused by coagulase-nega-
characteristics. 2001;142:604-10 tive staphylococci: an underappreciated disease. 2001;142:571
Marcus KA (see Miele et al). 2001;142:571-6 (Curriculum cardiol.) 6 (Curriculum cardiol.)
Marcus R (see Prakash et al). 2001;142:127-35 Migliorini A (see Antoniucci et al). 2001;142:684-90
Marinchak RA (see Ehlert et al). 2001;142:816-22 Miketic S, Carlsson J, Tebbe U. Randomized comparison of J&]
Mark DB (see Kandzari et al). 2001;142:843-51 Crown stent versus NIR stent after routine coronary angioplas-
Marmur JD (see Kini et al). 2001;142:965-9 ty. 2001;142:e8
Martelli M (see Padeletti et al). 2001;142:1047-55 Minamihaba O (see Hirono et al). 2001;142:1023
Martin C (see Kupferwasser et al). 2001; 142:146-52 Mincemoyer R (see Prasad et al). 2001;142:248-53
Martin DC (see Udris et al). 2001;142:1003-9 Minen G (see Gelsomino et al). 2001;142:556-62
Martins J (see Steinberg et al). 2001;142:520-9 Mintz GS (see Castagna et al). 2001;142:970-4
Masura J (see Mazic et al). 2001;142:482-8 Mirocha JM (see Brasch et al). 2001;142:1024-7
Mathew V, Farkouh ME, Gersh BJ, Rihal CS, Reeder GS, Grill DE, Mische T (see Auer et al). 2001;142:838-42
Urban LH, Kopecky SL, Chesebro JH, Holmes DR Jr. Early Mitchell LB (see Dzavik et al). 2001;142:119-26
coronary angiography improves long-term survival in unstable Mitchell LB (see Ehlert et al). 2001;142:816-22
angina. 2001;142:768-73 Mitchell LB (see Graham et al). 2001;142:254-61
Mathew V (see Al Suwaidi et al). 2001;142:452-9 Mitchell LB (see Hickey et al). 2001;142:99-104
Mathisen P (see Qi et al). 2001;142:725-32 Mitre CA (see Kini et al). 2001;142:965-9
Matsumoto Y (see Yoshitomi et al). 2001;142:445-51 Mittleman MA (see Mukamal et al). 2001;142:852-6
Matsushita T, Chun S, Sung RJ. Influence of isoproterenol on the Mohr-Kahaly S (see Kupferwasser et al). 2001;142:146-52
accelerated junctional rhythm observed during radiofrequency Mohr M (see Tsuchihashi et al). 2001;142:e7
catheter ablation of atrioventricular nodal slow pathway con- Mohsenifar Z (see Brasch et al). 2001;142:1024-7
duction. 2001;142:664-8 Molhock PG (see Peters et al). 2001;142:237-43
Maximal Individual Therapy in Acute Myocardial Infarction Monrad ES (see Kovar et al). 2001;142:e9
(MITRA) Study Group (see Zahn et al). 2001;142:105-11 Mooney D (see Senaratne et al). 2001;142:975-81
Maynard C, Wright SM, Every NR, Ritchie JL. Racial differences in Morelli A (see Gelsomino et al). 2001;142:5560-62
outcomes of veterans undergoing percutaneous coronary Morise AP. Interpreting the exercise electrocardiogram in patients
interventions. 2001;142:309-13 either on B-blocking drugs or with chronotropic incompe-
Mazic U, Gavora P, Masura J. The role of transesophageal tence. 2001;142:1-3 2 (Editorial)
echocardiography in transcatheter closure of secundum atrial Moritz S (see Simpson et al). 2001;142:e3
septal defects by the Amplatzer septal occluder. 2001;142:482- Morocutti G (see Gelsomino et al). 2001;142:556-62
8 Morris K (see Krucoff et al). 2001;142:760-7
McAnulty J (see Hickey et al). 2001;142:99-104 Moschi G (see Antoniucci et al). 2001;142:684-90
McCarthy WF (see Lundergan et al). 2001;142:43-50 Moscucci M (see Aronow et al). 2001;142:799-805
McCluskey ER (see Henry et al). 2001;142:872-80 Mueller HS (see Srinivas et al). 2001;142:29-36
McDonald J (see Wong et al). 2001;142:897-907 Mueller MN (see Furman et al). 2001;142:790-8
McDonell MB (see Udris et al). 2001;142:1003-9 Mukamal KJ, Maclure M, Sherwood JB, Kannam JP, Muller JE,
McFarlane A, Kamath MV, Fallen EL, Malcolm V, Cherian F, Mittleman MA. Height is not associated with long-term survival
Norman G. Effect of sertraline on the recovery rate of cardiac after acute myocardial infarction. 2001;142:852-6
autonomic function in depressed patients after acute myocar- Mukherjee D, Comella K, Bhatt DL, Roe MT, Patel V, Ellis SG.
dial infarction. 2001;142:617-23 Clinical outcome of a cohort of patients eligible for therapeu
McGovern P (see Vargas et al). 2001;142:1080-7 tic angiogenesis or transmyocardial revascularization. 2001;
McGuire DK (see Bahit et al). 2001;142:363-74. Correction 142:72-4
2001;142:678 Miller AM (see Kupferwasser et al). 2001;142:146-52
McGuire DK (see Patel and McGuire). 2001;142:388-90 (Editorial) Muller JE (see Mukamal et al). 2001;142:852-6
McKelvie RS (see Demers et al). 2001;142:698-703 Murphy S (see Srinivas et al). 2001;142:29-36
McKinney L (see Dolan et al). 2001;142:908-15 Musilli N (see Padeletti et al). 2001;142:1047-55
McMahon RP (see Sheps et al). 2001;142:864-71 Myers J, Bader D, Madhavan R, Froelicher V. Validation of a spe
McWhirter PD (see Fitzsimmons et al). 2001;142:530-6 cific activity questionnaire to estimate exercise tolerance in
Mehra MR (see Ventura et al). 2001;142:197-203 (Curriculum cardi- patients referred for exercise testing. 2001;142:1041-6
ol.) Myers J. On the uniformity of cardiopulmonary exercise testing in
Mehran R (see Castagna et al). 2001;142:970-4 chronic heart failure. 2001;142:384-7 (Editorial)
Mehta SK, Super DM, Salvator A, Singer L, Connuck D, Fradley MyersJ (see Prakash et al). 2001;142:127-35
Author index 1125
Myocardial Infarction Registry (MIR) Study Group (see Zahn et al) Otsuji S (see Izumi et al). 2001;142:782-9
2001;142:105-11 Ozdemir K, Altunkeser BB, S6kmen G, Tokag M, G6k H.
Usefulness of peak mitral inflow velocity to predict severe
mitral regurgitation in patients with normal or impaired left
ventricular systolic function. 2001:142:1065-71
Nagata M (see Shimizu et al). 2001;142:358-62 p
Nakajima K (see Shimizu et al). 2001;142:358-62
Nakamura H (see Hirono et al). 2001;142:1023
Nakano T (see Kitai et al). 2001;142:e1 Padeletti L, Pieragnoli P, Ciapetti C, Colella A, Musilli N, Porciani
Nanda NC (see Voros et al). 2001;142:916-22 MC, Ricci R, Pignalberi C, Santini M, Puglisi A, Azzolini P,
Nassar BA, Bevin LD, Johnstone DE, O'Neill BJ, Bata IR, Kirkland Spampinato A, Martelli M, Capucci A, Boriani G, Botto GL,
SA, Title LM. Relationship of the Glu298Asp polymorphism of Proclemer A. Randomized crossover comparison of right atrial
the endothelial nitric oxide synthase gene and early-onset appendage pacing versus interatrial septum pacing for preven-
coronary artery disease. 2001;142:586-9 tion of paroxysmal atrial fibrillation in patients with sinus
Negassa A (see Demers et al). 2001;142:698-703 bradycardia. 2001;142:1047-55
Negri E (see Volpi et al). 2001;142:87-92 age RL (see Joglar et al). 2001;142:498-501
Nesto RW (see Shubrooks et al). 2001;142:190-6 ajes G (see Ricci et al). 2001:142:e5
Nettles RE (see Meine et al). 2001;142:280-5 alatini P, Frigo G, Vriz O, Bertolo O, Dal Follo M, Daniele L,
Newburger JW (see Ross et al). 2001;142:233-6 (Meetings) Visentin P, Pessina AC, HARVEST Study Group. Early signs of
Newburger JW (see Valente et al). 2001;142:433-9 (Meetings) cardiac involvement in hypertension. 2001;142:1016-23
Newby LK. The emerging role of myoglobin for risk stratification antazis A (see Dilaveris et al). 2001;142:833-7
2001;142:4-6 (Editorial) apa A (see Acanfora et al). 2001;142:167-73
Nieminen MS (see Strandberg et al). 2001;142:952-9 (Trial design) app MA (see Kumar et al). 2001;142:512-15
Nikpoor B, Turecki G, Fournier C, Théroux P, Rouleau GA. A aridon SM (see Silber et al). 2001;142:577-85 (Trial design)
functional myeloperoxidase polymorphic variant is associated asini E (see Acanfora et al). 2001;142:167-73
with coronary artery disease in French-Canadians. 2001;142 asquale M (see Ricci et al). 2001;142:e5
336-9 asquali SK, Alexander KP, Peterson ED. Cardiac rehabilitation in
Nishikawa M (see Kitai et al). 2001;142:e1 the elderly. 2001;142:748-55 (Curriculum cardiol.)
Noble MIM (see Al-Obaidi et al). 2001;142:1002 assman R, Beshai J, Pavri B, Kimmel S. Predicting post-coronary
Norman G (see McFarlane et al). 2001;142:617-23 bypass surgery atrial arrhythmias from the preoperative elec-
Norris C (see Dzavik et al). 2001;142:119-26 trocardiogram. 2001;142:806-10
Norris CM (see Graham et al). 2001;142:254-61 itel MR, McGuire DK. Pounds of prevention: obesity therapy.
Nucifora R (see Gelsomino et al). 2001;142:556-62 2001;142:388-90 (Editorial)
Patel V (see Mukherjee et al). 2001;142:72-4
Pavri B (see Passman et al). 2001;142:806-10
PEACE Investigators (see Pfeffer et al). 2001;142:375-7 (Editorial)
2] Penn IM (see Berger et al). 2001;142:776-81
Pepine CJ (see Sheps et al). 2001;142:864-71
Al-Obaidi MK, Hon JKF, Stubbs PJ, Barnes J, Amersey RA, Dahdal Pessina AC (see Palatini et al). 2001;142:1016-23
M, Laycock JF, Noble MIM, Alaghband-Zadeh J. Plasma Peters RJG, Spickler W, Théroux P, White H, Gibson M, Molhock
insulin-like growth factor-1 elevated in mild-to-moderate but PG, Anderson HV, Weitz JI, Hirsh J, Weaver WD. Randomized
not severe heart failure. 2001;142:1002 comparison of a novel anticoagulant, vasoflux, and heparin as
O'Brien BJ (see Levy et al). 2001;142:537-43 adjunctive therapy to streptokinase for acute myocardial
O'Connor CM (see Felker and O’Connor). 2001;142:393-401 infarction: results of the VITAL study (Vasoflux International
(Curriculum cardiol.), 932-3 (Editorial) Trial for Acute Myocardial Infarction Lysis). 2001;142:237-43
O'Connor CM (see Whellan et al). 2001;142:160-6 Peterson DW (see Fitzsimmons et al). 2001;142:530-6
Oe K (see Shimizu et al). 2001;142:358-62 Peterson ED (see Alexander et al). 2001;142:37-42
Oetgen WJ (see Rathore et al). 2001;142:516-19 Peterson ED (see Pasquali et al). 2001;142:748-55 (Curriculum car-
Okeie K (see Shimizu et al). 2001;142:358-62 diol.)
Okinaka T (see Kitai et al). 2001;142:e1 Peterson GE (see Cabell et al). 2001;142:75-80
Okrainec K (see Huynh et al). 2001;142:960-4 Peterson LR, Eyster D, Davila-Roman VG, Stephens ALP,
Oku H (see Inoue et al). 2001;142:740-4 Schechtman KB, Herrero P, Gropler RJ. Short-term oral estro-
Ometto R (see La Vecchia et al). 2001;142:181-9 gen replacement therapy does not augment endothelium-inde-
O'Neill BJ (see Nassar et al). 2001;142:5806-9 pendent myocardial perfusion in postmenopausal women.
O'Neill WW (see George et al). 2001;142:857-63 2001;142:641-7
Ong PJL, Linardou H, Graham HA, Savage P, Hayward CS, Petit J (see Losay et al). 2001;142:544-8
Coombes RC, Collins P. Tamoxifen is not detrimental to endo- Petrillo MK (see Shahi et al). 2001;142:263-70
thelial function in postmenopausal women with breast cancer Peyser PA (see Aronow et al). 2001;142:799-805
2001;142:e6 Pfeffer M (see White et al). 2001;142:10506-64
O’Shea JC, DeMets DL. Statistical issues relating to international Pfeffer MA, Domanski M, VerterJ ,D unlap M, Flaker GC, Gersh B,
differences in clinical trials. 2001;142:21-8 (Meetings) Hsia J, Goldberg AD, Limacher MC, Maggioni AP, Rosenberg Y,
O'Shea JC, Fu Y, Chang W-C, Armstrong PW. A tale of two coun- Rouleau J-L, WarnicaJW , Wasserman AG, Braunwald E, PEACE
tries: insights from the differences in Canadian/American pat- Investigators. The continuation of the Prevention of Events
terns of care for patients with acute coronary syndromes With Angiotensin-Converting Enzyme Inhibition (PEACE)
2001;142:14-20 (Meetings) Trial. 2001;142:375-7 (Editorial)
O'Shea JC (see Bahit et al). 2001;142:363-74. Correction 2001;142 Pfeifer PB (see Strzelczyk et al). 2001;142:466-75
678 Phillips HR (see Lederman et al). 2001;142:314-23
Otaki M (see Inoue et al). 2001;142:740-4 Pi-Sunyer X (see Rao et al). 2001;142:1102-7 (Meetings)
1126 Author index
Picco D (see Gattone et al). 2001;142:633-40 Reeder GS (see Al Suwaidi et al). 2001;142:452-9
Pichard AD (see Castagna et al). 2001;142:970-4 Reeder GS (see Mathew et al). 2001;142:768-73
Picone C (see Acanfora et al). 2001;142:167-73 Regar E (see Albertal et al). 2001;142:81-6
Piedad B (see Kort et al). 2001;142:4706-81 Reich D (see Kini et al). 2001;142:965-9
Piek JJ (see Albertal et al). 2001;142:81-6 ReinerJ S (see Lundergan et al). 2001;142:43-50
Pieper K (see Furman et al). 2001; 142:790-8 Reisin L (see Schalcher et al). 2001;142:340-9
Pieragnoli P (see Padeletti et al). 2001;142:1047- Renfroe EG (see Ehlert et al). 2001;142:816-22
Pignalberi C (see Padeletti et al). 2001;142:1047- Rengo F (see Acanfora et al). 2001;142:167-73
Pilote L (see Beck et al). 2001;142:271-9 RESOLVD Pilot Study Investigators (see Demers et al). 2001;142
PIMI Investigators (see Sheps et al). 2001;142:864-71 698-704
Pitkala K (see Strandberg et al). 2001;142:952-9 (Trial design) Riad K (see Dolan et al). 2001;142:908-15
Poldermans D (see Sozzi et al). 2001;142:153-9 Ribakove GH (see Kort et al). 2001;142:476-81
Pond KK (see Cabell et al). 2001;142:75-80 Ricci R, Coletta C, Ceci V, Pajes G, Putini RL, Salustri A, Bottero G,
Popma JJ. Stent selection in clinical practice: have clinical trials Pasquale M, RIMA Researchers. Effect of early treatment with
provided the evidence we need? 2001;142:378-80 (Editorial) captopril and metoprolol singly and together on postinfarction
Porciani MC (see Padeletti et al). 2001;142:1047-55 left ventricular remodeling. 2001;142:e5
Power JA (see Stone et al). 2001;142:679-83 Ricci R (see Ansalone et al). 2001;142:881-96
Prakash M, Myers J, Froelicher VF, Marcus R, Do D, Kalisetti D, Ricci R (see Padeletti et al). 2001;142:1047-55
Froning J, Atwood JE. Diagnostic exercise tests on 4000 con Rihal CS (see Mathew et al). 2001:142:768-73
secutive men. 2001;142:127-35 RIMA Researchers (see Ricci et al). 2001;142:e5
Prasad A, Koh KK, Schenke WH, Mincemoyer R, Csako G, Ritchie JL (see Maynard et al). 2001;142:309-13
Fleischer TA, Brown M, Selvaggi TA, Quyyumi AA. Role of Rocha-Singh K (see Henry et al). 2001;142:872-80
angiotensin II type 1 receptor in the regulation of cellular Roe MT (see Mukherjee et al). 2001;142:72-4
adhesion molecules in atherosclerosis. 2001;142:248-53 Roelandt JRTC (see Sozzi et al). 2001;142:153-9
Proclemer A (see Padeletti et al). 2001;142:1047-55 Rogers W] (see Manhapra et al). 2001;142:604-10
Puglisi A (see Padeletti et al). 2001;142:1047-55 Rollan MJ (see San Roman et al). 2001;142:1037-40
Puri S (see Dolan et al). 2001;142:908-15 Rosahl W (see Zahn et al). 2001;142:105-11
Puri VK (see Voros et al). 2001;142:916-22 Rosenberg Y (see Pfeffer et al). 2001;142:375-7 (Editorial)
Putini RL (see Ricci et al). 2001;142:e5 Rosenthal J (see Miele et al). 2001;142:571-6 (Curriculum cardiol.)
Pyatt L (see Dolan et al). 2001;142:908-15 ROSETTA Investigators (see Huynh et al). 2001;142:960-4
Ross AM, Gao R, Coyne KS, Chen J, Yao K, Yang Y, Qin X, Qiao
S, Yao M, TUCC Investigators. A randomized trial confirming
the efficacy of reduced dose recombinant tissue plasminogen
Q activator in a Chinese myocardial infarction population and
demonstrating superiority to usual dose urokinase: the TUC¢
Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjornerheim R, trial. 2001;142:244-7
Endresen K, Hall C. Natriuretic peptides in patients with aortic Ross AM (see Lundergan et al). 2001;142:43-50
stenosis. 2001;142:725-32 Ross LF, NewburgerJ W, Sanders SP. Ethical issues in pediatric tri
Qiao S (see Ross et al). 2001;142:244-7 als. 2001;142:233-6 (Meetings)
Qin X (see Ross et al). 2001;142:244-7 Réssberg J (see Johanson et al). 2001;142:58-62
QOLAMI Investigators (see Beck et al). 2001;142:271-9 Rouleau GA (see Nikpoor et al). 2001;142:336-9
Quigg RJ (see Strzelczyk et al). 2001;142:466-75 Rouleau J-L (see Pfeffer et al). 2001;142:375-7 (Editorial)
Quyyumi AA (see Prasad et al). 2001;142:248-53 Rouleau JL (see White et al). 2001;142:1056-64
Roux L (see Gauri et al). 2001;142:1306-41
Rowe E (see Dujovne et al). 2001;142:489-97
Russman PL (see Aronow et al). 2001;142:799-805
Russo A (see Steinberg et al). 2001;142:520-9
Rutkowsky M (see Silber et al). 2001;142:577-85 (Trial design)
Raczynski JM (see Sheps et al). 2001;142:864-71 Ruzyllo W (see Tendera et al). 2001;142:93-8
Radford MJ (see Shahi et al). 2001;142:263-70 Ryan T (see Cabell et al). 2001;142:75-80
Radford MJ (see Wexler et al). 2001;142:350-7 Rychik J (see Silber et al). 2001;142:577-85 (Trial design)
Ramaswamy K (see Joglar et al). 2001;142:498-501
Rame JE, Sheffield MA, Dries DL, Gardner EB, Toto KH, Yancy
CW, Drazner MH. Outcomes after emergency department dis
charge with a primary diagnosis of heart failure. 2001;142:714- Ss
19
Ramee S (see Cohen et al). 2001;142:648-56 Sadanandan S, Buller C, Menon V, Dzavik V, Terrin M, Thompson
Randazzo D (see Bisaccia et al). 2001;142:461-5 B, Lamas G, Hochman JS. The late open artery hypothesis—a
Rao SV, Donahue M, Pi-Sunyer X, Fuster V. Obesity as a risk fac- decade later. 2001;142:411-21 (Prog. cardiol.)
tor in coronary artery disease. 2001;142:1102-7 (Meetings) Sadanandan §S (see Steinberg et al). 2001;142:520-9
Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Schulman KA, Sakurai M (see Izumi et al). 2001;142:782-9
Solomon AJ. The role of reperfusion therapy in paced patients Salaymeh KJ, Banerjee A. Evaluation of arterial stiffness in chil-
with acute myocardial infarction. 2001;142:516-19 dren with Williams syndrome: does it play a role in evolving
Rathore SS (see Shahi et al). 2001;142:263-70 hypertens‘on? 2001;142:549-55
Ravi KL (see Kovar et al). 2001;142:e9 Salustri 4 « ge Ricci et al). 2001;142:e5
Raxwal VK (see Gauri et al). 2001;142:136-41 Salvator A (see Mehta et al). 2001;142:828-32
Redberg R (see Kim et al). 2001;142:934-44 (Curriculum cardiol.) Samal AK (see Voros et al). 2001;142:916-22
Reddan D (see Bahit et al). 2001;142:363-74. Correction San Roman JA, Vilacosta I, Sarria C, Garcimartin I, Rollan MJ,
2001;142:678 Fernandez-Avilés F. Eustachian valve endocarditis: is it worth
Reddy CVR (see Das et al). 2001;142:756-9 (Curriculum cardiol.) searching for? 2001;142:1037-40